A 6-month-old infant received routine immunizations 2 hours ago and now presents with mild drowsiness, low-grade fever, and slight swelling at the injection site. The parents are concerned about their child's reaction. What is the most appropriate nursing intervention?

Post-vaccination reactions like fever, irritability, and local redness are common and expected. Cool compresses reduce inflammation, and acetaminophen is safe for fever management in infants over 2 months. Other options are inappropriate: aspirin is contraindicated, heat can worsen inflammation, and withholding vaccinations is not indicated for these mild reactions.

Understanding the Scenario
This question describes a 6-month-old infant who is exhibiting a classic, mild post-immunization reaction. The symptoms of mild drowsiness, a low-grade fever, and slight swelling at the injection site occurring a few hours after vaccination are not a sign of a severe adverse event, but rather an expected physiological response. The body's immune system is recognizing the vaccine antigen and mounting a protective response, which involves a localized inflammatory process and the release of cytokines that can cause systemic symptoms like fever and malaise ^[2]. The parents' concern is a common and valid nursing care priority that requires both a safe, evidence-based intervention and thorough parent education.

Analysis of the Correct Answer (Option 2)
The most appropriate intervention is to apply a cool compress to the injection site and administer acetaminophen as ordered. This choice directly addresses both the local and systemic symptoms with the safest and most effective modalities for an infant.

- Local Comfort: A cool compress provides a non-pharmacological strategy for managing the localized pain and swelling at the injection site. The updated Cochrane review on procedural pain management in infants supports the use of such physical strategies to reduce discomfort ^[1]. The cool temperature causes local vasoconstriction, which can limit the spread of the inflammatory exudate, reduce edema, and provide a numbing effect that eases pain.
- Systemic Symptom Management: Acetaminophen is the antipyretic and analgesic of choice for infants. It works centrally to reduce the hypothalamic set-point that has been elevated by vaccine-induced pyrogens, effectively lowering the low-grade fever and relieving the associated generalized discomfort and drowsiness. The phrasing "as ordered" is critical, as it reflects the nurse's scope of practice to administer a standing or prescribed PRN medication based on a valid clinical assessment.

Analysis of Incorrect Options

- Option 1: Administer aspirin to reduce fever and inflammation. This is a dangerous and contraindicated intervention in infants and children. Aspirin use during a viral illness or post-vaccination fever is associated with Reye's syndrome, a rare but life-threatening condition causing acute encephalopathy and fatty liver degeneration. Acetaminophen and ibuprofen are the only appropriate over-the-counter antipyretics for this age group, and ibuprofen is generally not recommended for infants under 6 months. This option is a critical safety violation.

- Option 3: Apply a warm compress to the injection site for 20 minutes. While warm compresses are beneficial for certain types of inflammation (e.g., to promote drainage of an abscess or resolve a hematoma), they are not the first-line comfort measure for acute, non-infected injection site reactions. Heat causes vasodilation, which could theoretically increase swelling and discomfort in the immediate post-injection period. A cool compress is the standard, evidence-based non-pharmacological comfort measure for this acute, procedural-type pain and swelling ^[1].

- Option 4: Withhold all future vaccinations due to adverse reaction. This action is a serious error that would leave the infant vulnerable to preventable diseases. The symptoms described are mild, expected, and self-limiting, not a true contraindication to future vaccination. A severe allergic reaction (anaphylaxis) or encephalopathy not attributable to another cause would warrant withholding a specific vaccine component, but a low-grade fever and local swelling are explicitly not reasons to discontinue the immunization schedule. The safety profile of vaccines, as monitored by systems like VAERS, confirms that while mild reactions are common, severe adverse events are rare, and the benefits of continued protection far outweigh the risks of these transient side effects ^[2].